Overview

Flu Vaccines Market Dynamics:

Influenza is a contagious respiratory infection that causes cough, runny nose, severe illness. As per the World Health Organization, 2018, over 4 million people were diagnosed with severe illness whereas over 0.1 million influenza-related deaths were registered. Additionally, as per the report published by Center for Disease Control and Prevention in 2019, over 90 pediatric deaths were registered owing to flu. Furthermore, growing research and development activities along with current clinical trials for developing novel flu vaccines shall bolster the flu vaccines market growth.
Moreover, rise in the number of healthcare centers in both developed and developing nations has boosted the proliferation of the market. Additionally, many key players are heavily investing in research and development activities for increasing their manufacturing capabilities and the product spectrum. These vendors are establishing new facilities for enhancing their production capabilities. The demand for flu vaccines has skyrocketed due to the current COVID-19 pandemic and many companies are initiating in producing vaccines for this virus. For example, Bharat Biotech has declared to collaborate with FluGen, a US-based biotech company and the University of Wisconsin Madison for experimenting with flu vaccines that have the potential of fighting off the SARS COV-2 virus. Many players have also reached the levels of advance clinical trials and government bodies are providing financial as well as infrastructural support to these companies.

Flu Vaccines Market Segmentation:

By Product Type
• Trivalent Flu Vaccines
• Quadrivalent Flu Vaccines

By Dosage Form
• Intramuscular Injection
• Nasal Sprays
• Intradermal Shot

By Distribution Channel
• Hospitals
• Community Clinics
• Public Health Agencies
• Workplace Purchasing
• Retail Pharmacy
• Mail Order Pharmacy

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

The market is categorized into product type, dosage form, distribution channel and region. The product type segment is fragmented into trivalent vaccines and quadrivalent vaccines. The dosage form segment is classified into intradermal shots, intramuscular injection and nasal shots. The distribution channel segment is diversified into hospitals, community clinics, public health agencies, workplace purchasing, retail pharmacy and mail order pharmacy. The hospital segment is anticipated to hold the largest flu vaccines market share owing to a rise in the number of multispecialty hospitals and advancements in the hospital infrastructure.

Regional Analysis:
The North America region is expected to dominate the market and this can be credited to the rising awareness regarding the spread and prevention of flu, growing investments in the research and development of flu vaccines, favorable reimbursement policies and a strong presence of key market players in the region. The Europe region has experienced the growing prevalence of flu in the region which has boosted the market growth in the region.

Competitive Landscape:                            
The major market players associated are Sanofi Pasteur Inc. (Sanofi S/A), AstraZeneca, Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., CSL Ltd. (Seqirus), Zydus Cadila, Bharat Biotech, Panacea Biotech, Mylan, Sinovac Biotech,Mitsubishi Tanabe Pharma.

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global flu vaccines market by product type, by dosage form, by distribution channel and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
         1.3.1 Years Considered for the Study
         1.3.2 Market Covered
     1.4 Currency
     1.5 Limitations
     1.6 Stakeholders
2. Research Methodology
     2.1 Research Data
           2.1.1 Secondary Data
                  2.1.1.1 Key Data from Secondary Sources
           2.1.2 Primary Data
                  2.1.2.1 Key Data from Primary Sources
     2.2 Market Size Estimation
     2.3 Market Breakdown and Data Triangulation
     2.4 Assumptions for the Study  
3. Executive Summary
      3.1 Market Outlook
      3.2 Segment Outlook
      3.3 Competitive Insights
4. Market Variables, Trends & Scope
      4.1 Market Lineage Outlook
      4.2 Penetration and Growth Prospect Mapping
      4.3 Industry Value Chain Analysis
      4.4 Cost Analysis Breakdown
      4.5 Technology Overview
      4.6 Regulatory Framework on Country Level
           4.6.1 Reimbursement Framework    
           4.6.2 Standards and Compliances
5. Market Overview
      5.1 Market Dynamics
          5.1.1 Market Driver Analysis
          5.1.2 Market Restraint Analysis
          5.1.3 Industry Challenges                 
6. Market Analysis tools
      6.1 Industry Analysis - Porter’s
            6.1.1 Supplier Power
            6.1.2 Buyer Power
            6.1.3 Substitution Threat
            6.1.4 Threat from new entrants
            6.1.5 Competitive Rivalry                
       6.2 Pestel Analysis
            6.2.1 Political Landscape
            6.2.2 Environmental Landscape
            6.2.3 Social landscape
            6.2.4 Technology landscape
            6.2.5 Legal Landscape
7. Flu Vaccines Market, By Product Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
       7.1 Trivalent Vaccines
       7.2 Quadrivalent Vaccines
8. Flu Vaccines Market, By Dosage Form Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
        8.1 Intramuscular Injection
        8.2 Nasal Sprays
        8.3 Intradermal Shots
9. Flu Vaccines Market, By Distribution Channel Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
        9.1 Hospitals  
        9.2 Community Clinics
        9.3 Public Health Agencies
        9.4 Workplace Purchasing
        9.5 Retail Pharmacy
        9.6 Mail Order Pharmacy    
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
            10.2.1. U.S.
            10.2.2. Canada
            10.2.3. Mexico
            10.2.4 Rest of North America
    10.3 Market Size (USD Mn) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    11.1. Introduction
    11.2. Regional Market Trends
    11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
             11.3.1. Brazil
             11.3.2. Uruguay
             11.3.3 Argentina
             11.3.4. Rest of Latin America
    11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
             12.2.1. Germany
             12.2.2. U.K
             12.2.3. France
             12.2.4. Italy
             12.2.5 Switzerland
             12.2.6. Spain
             12.2.7. Russia
             12.2.8. Poland
             12.2.9. Rest of Western Europe
      12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
      13.1 Introduction
      13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
             13.2.1 Japan
             13.2.2 China
             13.2.3 Singapore
             13.2.4 Korea        
             13.2.5 India
             13.2.6 Australia and New Zealand
             13.2.7 ASEAN
             13.2.8 Rest of Asia Pacific
    13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
      14.1 Introduction
      14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
              14.2.1 UAE
              14.2.2 South Africa
              14.2.3 Egypt
              14.2.4 Saudi Arabia
              14.2.5 Rest of MEA
14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    15.1. Sanofi Pasteur Inc. (Sanofi S/A)
          15.1.1. Company Overview
          15.1.2. Product Portfolio
          15.1.3. SWOT Analysis
          15.1.4. Financial Overview
          15.1.5. Strategic Overview
    15.2. AstraZeneca
          15.2.1. Company Overview
          15.2.2. Product Portfolio
          15.2.3. SWOT Analysis
          15.2.4. Financial Overview
          15.2.5. Strategic Overview 
    15.3. Abbott
          15.3.1. Company Overview
          15.3.2. Product Portfolio
          15.3.3. SWOT Analysis
          15.3.4. Financial Overview
          15.3.5. Strategic Overview
    15.4. GlaxoSmithKline Plc.
          15.4.1. Company Overview
          15.4.2. Product Portfolio
          15.4.3. SWOT Analysis
          15.4.4. Financial Overview
          15.4.5. Strategic Overview
     15.5. Serum Institute of India Pvt. Ltd.
          15.5.1. Company Overview
          15.5.2. Product Portfolio
          15.5.3. SWOT Analysis
          15.5.4. Financial Overview
          15.5.5. Strategic Overview          
     15.6. CSL Ltd. (Seqirus)
          15.6.1. Company Overview
          15.6.2. Product Portfolio
          15.6.3. SWOT Analysis
          15.6.4. Financial Overview
          15.6.5. Strategic Overview      
    15.7. Zydus Cadila
          15.7.1. Company Overview
          15.7.2. Product Portfolio
          15.7.3. SWOT Analysis
          15.7.4. Financial Overview
          15.7.5. Strategic Overview
    15.8. Bharat Biotech
          15.8.1. Company Overview
          15.8.2. Product Portfolio
          15.8.3. SWOT Analysis
          15.8.4. Financial Overview
          15.8.5. Strategic Overview 
    15.9. Panacea Biotech
          15.9.1. Company Overview
          15.9.2. Product Portfolio
          15.9.3. SWOT Analysis
          15.9.4. Financial Overview
          15.9.5. Strategic Overview
   15.10. Mylan
          15.10.1. Company Overview
          15.10.2. Product Portfolio
          15.10.3. SWOT Analysis
          15.10.4. Financial Overview
          15.10.5. Strategic Overview
   15.11. Sinovac Biotech
          15.11.1. Company Overview
          15.11.2. Product Portfolio
          15.11.3. SWOT Analysis
          15.11.4. Financial Overview
          15.11.5. Strategic Overview
   15.12. Mitsubishi Tanabe Pharma
          15.12.1. Company Overview
          15.12.2. Product Portfolio
          15.12.3. SWOT Analysis
          15.12.4. Financial Overview
          15.12.5. Strategic Overview
16 Impact of COVID-19
   16.1. Positive influence on the healthcare industry
   16.2. The financial disruption of the manufacturing sector
   16.3. Impact of COVID-19 on emerging companies
   16.4. Significant mandates in the healthcare regulations initiated by administrations
   16.5. The overall economic slowdown of the developing and developed nations
17 Competitive Intelligence and Competitive Matrix
   17.1 Competitive Intelligence
   17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis
   18.1 Joint ventures
   18.2 Mergers and acquisitions
   18.3 Licensing and partnerships
   18.4 Technology Collaborations
   18.5 Strategic Divestments
   18.6 Market Entry Strategies         
19. Relevant Case Studies and Latest News Updates
20. Key Market Takeaway Points from the Market Analysts at FutureWise Market Research

Tables

Figures